Stage IV Cervical Cancer AJCC v8

14 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942)	National Cancer Institute (NCI)	2021-08-25
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)	City of Hope Medical Center	2019-12-24
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients (NCT03987555)	Wake Forest University Health Sciences	2019-11-11
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers (NCT03968406)	M.D. Anderson Cancer Center	2019-09-26
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085)	M.D. Anderson Cancer Center	2018-11-14
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer (NCT02140021)	M.D. Anderson Cancer Center	2014-10-27
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix (NCT04723095)	M.D. Anderson Cancer Center	2013-05-16

Every clearance here is in the API, with alerts when new ones post.